Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1966 Feb;29(1):85–90. doi: 10.1136/jnnp.29.1.85

Excretion of 5-hydroxyindolyl acetic acid (5HIAA) in migraine.

G Curzon, P Theaker, B Phillips
PMCID: PMC495989  PMID: 5910583

Full text

PDF
85

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS B. Serum-5-hydroxytryptamine levels following experimental increase in gastrointestinal activity in man. Lancet. 1960 Jan 23;1(7117):207–208. doi: 10.1016/s0140-6736(60)90119-7. [DOI] [PubMed] [Google Scholar]
  2. BARTTER F. C., DELEA C. S. A map of blood and urinary changes related to circadian variations in adrenal cortical function in normal subjects. Ann N Y Acad Sci. 1962 Oct 30;98:969–983. doi: 10.1111/j.1749-6632.1962.tb30612.x. [DOI] [PubMed] [Google Scholar]
  3. BULBRING E., LIN R. C. The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of 5-HT and its release in relation to intraluminal pressure and propulsive activity. J Physiol. 1958 Mar 11;140(3):381–407. [PMC free article] [PubMed] [Google Scholar]
  4. BUTT W. D., LEES H. Nitrite oxidation by Nitrobacter in the presence of certain nitrophenols. Nature. 1960 Oct 8;188:147–148. doi: 10.1038/188147b0. [DOI] [PubMed] [Google Scholar]
  5. Bertaccini G., Baronio G. Urinary excretion of 5-hydroxyindoleacetic acid after administration of fluid in man. Arch Int Pharmacodyn Ther. 1965 May;155(1):57–62. [PubMed] [Google Scholar]
  6. CAMPBELL D. A., HAY K. M., TONKS E. M. An investigation of the salt and water balance in migraine. Br Med J. 1951 Dec 15;2(4745):1424–1429. doi: 10.1136/bmj.2.4745.1424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CURRAN D. A., LANCE J. W. CLINICAL TRIAL OF METHYSERGIDE AND OTHER PREPARATIONS IN THE MANAGEMENT OF MIGRAINE. J Neurol Neurosurg Psychiatry. 1964 Oct;27:463–469. doi: 10.1136/jnnp.27.5.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. CURZON G., WALSH J. A method for the determination of urinary indoxyl sulphate (indican). Clin Chim Acta. 1962 Sep;7:657–663. doi: 10.1016/0009-8981(62)90147-x. [DOI] [PubMed] [Google Scholar]
  9. DEGKWITZ R., FROWEIN R., KIRBERGER E., KULENKAMPFF C., MOHS U. [On normal values of hourly 5-hydroxyindolacetic acid in the urine in man and factors interrupting the measurements]. Klin Wochenschr. 1962 Mar 15;40:285–289. doi: 10.1007/BF01732620. [DOI] [PubMed] [Google Scholar]
  10. ERSPAMER V., BERTACCINI G. Observations on the antidiuretic action and the fate of 5-hydroxy-DL-tryptophan in the rat organism. Arch Int Pharmacodyn Ther. 1962 May 1;137:6–23. [PubMed] [Google Scholar]
  11. HENDRIX T. R., ATKINSON M., CLIFTON J. A., INGELFINGER F. J. The effect of 5-hydroxytryptamine on intestinal motor function in man. Am J Med. 1957 Dec;23(6):886–893. doi: 10.1016/0002-9343(57)90298-x. [DOI] [PubMed] [Google Scholar]
  12. JEPSON J. B. Paper chromatography of urinary indoles. Lancet. 1955 Nov 12;269(6898):1009–1011. doi: 10.1016/s0140-6736(55)93432-2. [DOI] [PubMed] [Google Scholar]
  13. KIMBALL R. W., FRIEDMAN A. P., VALLEJO E. Effect of serotonin in migraine patients. Neurology. 1960 Feb;10:107–111. doi: 10.1212/wnl.10.2.107. [DOI] [PubMed] [Google Scholar]
  14. KIRBERGER E., BRAUN L. [On the occurrence of 5-hydroxytryptamine in the walnut (Juglans regia)]. Biochim Biophys Acta. 1961 May 13;49:391–393. doi: 10.1016/0006-3002(61)90141-x. [DOI] [PubMed] [Google Scholar]
  15. MARCUSSEN R. M., WOLFF H. G. Effects of carbon dioxide-oxygen mixtures given during preheadache phase of the migraine attack; further analysis of the pain mechanisms in headache. Arch Neurol Psychiatry. 1950 Jan;63(1):42–51. [PubMed] [Google Scholar]
  16. OSTFELD A. M. Migraine headache: its physiology and biochemistry. JAMA. 1960 Oct 29;174:1188–1190. doi: 10.1001/jama.1960.63030090011010. [DOI] [PubMed] [Google Scholar]
  17. PISANO J. J., CROUT J. R., ABRAHAM D. Determination of 3-methoxy-4-hydroxymandelic acid in urine. Clin Chim Acta. 1962 Mar;7:285–291. doi: 10.1016/0009-8981(62)90022-0. [DOI] [PubMed] [Google Scholar]
  18. PISANO J. J., OATES J. A., Jr, KARMEN A., SJOERDSMA A., UDENFRIEND S. Identification of p-hydroxy-alpha-(methylaminomethyl) benzyl alcohol (synephrine) in human urine. J Biol Chem. 1961 Mar;236:898–901. [PubMed] [Google Scholar]
  19. ROSENFELD G. Inhibitory influence of ethanol on serotonin metabolism. Proc Soc Exp Biol Med. 1960 Jan;103:144–149. doi: 10.3181/00379727-103-25440. [DOI] [PubMed] [Google Scholar]
  20. SCHIEVELBEIN H., SURBERG U., WERLE E. [Increase of excretion of 5-hydroxyindolacetic acid in smokers]. Klin Wochenschr. 1962 Jan 1;40:52–53. doi: 10.1007/BF01483451. [DOI] [PubMed] [Google Scholar]
  21. SICUTERI F. PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES. Triangle. 1963 Oct;67:116–125. [PubMed] [Google Scholar]
  22. Sicuteri F., Fanciullacci M., Del Bianco P. L., Franchi G. Inibizione della venocostrizione da 5-idrossitriptamina nell'uomo da parte del metisergide (UMI-491) e di altri antiserotonici. Boll Soc Ital Biol Sper. 1964 Oct 15;40(19):1151–1152. [PubMed] [Google Scholar]
  23. TODRICK A., DICK M., TAIT A. C. Effect of reserpine in therapeutic dosage on excretion of 5-hydroxyindoleacetic acid. Br Med J. 1958 Mar 1;1(5069):496–499. doi: 10.1136/bmj.1.5069.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. WESTFALL T. C., WATTS D. T. CATECHOLAMINE EXCRETION IN SMOKERS AND NONSMOKERS. J Appl Physiol. 1964 Jan;19:40–42. doi: 10.1152/jappl.1964.19.1.40. [DOI] [PubMed] [Google Scholar]
  25. Waalkes T. P., Sjoerdsma A., Creveling C. R., Weissbach H., Udenfriend S. Serotonin, Norepinephrine, and Related Compounds in Bananas. Science. 1958 Mar 21;127(3299):648–650. doi: 10.1126/science.127.3299.648. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES